# Pluriomics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/pluriomics-b-v

- Industry: Biotechnology
- Headquarters: Leiden, Netherlands
- Website: www.pluriomics.com
- Total disclosed funding: $5M
- Latest round: Series A (Oct 15, 2014)
- Investors on record: 3

## About

Pluriomics B.V. is a biotechnology company focused on developing and supplying human induced pluripotent stem cells (iPSCs) and associated technologies to improve drug discovery and development processes.Founded in 2011 in Leiden, Netherlands, Pluriomics B.V. specializes in iPSC technology. The company raised EUR 2.5 million in March 2017 from investors Sambrinvest and SFPI-FPIM, marking its third deal. No significant changes in business strategy have been reported since inception.Pluriomics B.V. develops human induced pluripotent stem cells (iPSCs) and related technologies designed to enhance drug discovery and development. Their primary offerings include high-quality cell models, screening assays, and iPSC differentiation processes tailored for pharmaceutical and biotechnology companies across North America, Europe, and Asia.Pluriomics B.V. generates revenue through direct B2B transactions with drug developers and researchers. Their services encompass custom iPSC reprogramming, gene editing, and differentiation services, which are typically arranged as project-based contracts. Notable products, such as Ncyte® Microglia, contribute to their revenue generation, with pricing determined through negotiations based on client needs.Following their most recent funding round in March 2017, which raised EUR 2.5 million, Pluriomics B.V. aims to expand its product offerings and enhance existing technologies. The company is exploring new markets across Europe and Asia, with plans to launch additional iPSC-based products by the end of 2024. The new funding will be allocated towards research and development initiatives to support these expansions.

## Funding rounds

- Series A, Oct 15, 2014, $5M — Société Régionale d'Investissement de Wallonie, Vesalius Biocapital, InnovationQuarter

## Investors

- Société Régionale d'Investissement de Wallonie — Series A
- Vesalius Biocapital (https://capitalatlas.ai/funds/vesalius-biocapital) — Series A
- InnovationQuarter (https://capitalatlas.ai/funds/innovationquarter) — Series A